Monthly Investment: Wegovy vs Mounjaro Cost Analysis
Monthly Cost Structure: Mounjaro vs Wegovy UK Comparison
When evaluating Mounjaro vs Wegovy UK monthly costs, the financial commitment varies significantly throughout your treatment journey. Wegovy follows a structured 16-week dose escalation starting at £79.99 monthly for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), and £139.99 (1.7mg) before reaching the maintenance dose of 2.4mg at £209.99 per month. Mounjaro follows a different escalation pattern with its own pricing structure, though both treatments require similar long-term financial planning. The key difference lies not just in monthly cost but in the underlying mechanisms—Wegovy's semaglutide targets GLP-1 receptors exclusively, while Mounjaro's tirzepatide provides dual GIP and GLP-1 receptor activation.
Understanding the Mounjaro vs Wegovy UK cost comparison requires considering your individual treatment timeline and response. Most patients reach Wegovy's maintenance dose by week 17, meaning your monthly investment stabilises at £209.99 from that point forward. Both treatments are prescription-only medicines requiring ongoing clinical supervision, and the monthly cost reflects not just the medication but the comprehensive care pathway. At EverydayMeds, we ensure transparent pricing with discount codes applied at checkout—FIRST40 for new customers and DOSE25 for returning patients—so you know exactly what each month will cost throughout your weight management journey.
Wegovy Pricing Structure and Bundle Value Options
Our Wegovy pricing reflects the clinical dose escalation protocol essential for treatment tolerance and efficacy. Starting with the 0.25mg dose at £79.99, patients progress through carefully calibrated increases every four weeks. The month 5-8 phase costs £94.99 for 0.5mg, followed by £99.99 for 1mg during weeks 9-12, then £139.99 for the 1.7mg dose in weeks 13-16. From week 17 onwards, the maintenance 2.4mg dose requires a monthly investment of £209.99. These prices include our discount codes applied at checkout, ensuring complete cost transparency from your first order.
For patients seeking supply security and convenience, our bundle options provide multiple months of treatment in a single order. The Intro Duo (0.25mg and 0.5mg) covers your first two months for £169.99, while the Ultimate Stability Trio provides three months of maintenance 2.4mg supply for £649.99. Bundle pricing focuses on convenience rather than savings—ensuring you never risk treatment interruption due to supply gaps. All bundles include next-day cold-chain delivery and are dispensed from our GPhC-registered pharmacy (#9012878), maintaining the same clinical standards as individual pen orders.
Clinical Evidence Supporting Mounjaro vs Wegovy UK Treatment Decisions
The STEP clinical trial programme demonstrates Wegovy's efficacy in weight management when used alongside a reduced-calorie diet and increased physical activity. In the landmark STEP 1 trial published by Wilding et al. in NEJM 2021, participants taking Wegovy achieved an average weight reduction of approximately 15% at 68 weeks, compared to 2.4% with placebo. The STEP 2 trial showed sustained efficacy in patients with type 2 diabetes, while STEP 5 confirmed long-term maintenance of weight loss over two years.
Mounjaro's clinical evidence comes from the SURMOUNT trials, demonstrating the potential benefits of dual GIP/GLP-1 receptor activation. However, when considering Mounjaro vs Wegovy UK treatment options, it's important to note that direct head-to-head comparisons aren't available due to different trial designs and patient populations. Both medications may support significant weight management outcomes, though individual responses vary and ongoing clinical supervision remains essential for optimal results.
How Wegovy Works: GLP-1 Mechanism and Monthly Treatment
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of a natural hormone produced in your intestines after eating. This hormone signals to your brain that you're satisfied, helping reduce appetite and the urge to eat between meals. Unlike Mounjaro's dual-action approach targeting both GIP and GLP-1 receptors, Wegovy focuses specifically on GLP-1 pathways that regulate hunger and satiety. The once-weekly injection maintains steady medication levels, providing consistent appetite regulation throughout each month of treatment. The gradual dose escalation over 16 weeks allows your body to adapt to the medication while minimising potential side effects, ensuring you can maintain your monthly treatment routine effectively.
Ordering Process: From Assessment to Monthly Delivery
Starting your Wegovy treatment begins with our 3-minute online clinical assessment, designed to evaluate your suitability for this prescription-only medicine. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring appropriate clinical oversight before dispensing. Once approved, your first month's supply ships via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements essential for medication stability. Our automated reminder system helps you order subsequent months' supply with adequate time for prescriber review and delivery. This streamlined process ensures your monthly treatment arrives consistently, supporting uninterrupted progress through your weight management journey.
Storage Advantages: Wegovy vs Mounjaro UK Practical Considerations
When comparing Mounjaro vs Wegovy UK storage requirements, Wegovy offers superior flexibility for active lifestyles and travel. While both medications require refrigeration at 2-8°C before first use, Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. This storage advantage makes Wegovy particularly suitable for patients who travel frequently or prefer flexible medication storage options. The FlexTouch pen system delivers precise doses with an easy-to-use design, and each pen provides four weeks of treatment at your prescribed dose. Understanding these practical differences helps inform your monthly treatment choice alongside clinical and cost considerations.
Long-term Cost Planning: Annual Investment for Mounjaro vs Wegovy UK
Planning your annual investment in weight management medication requires understanding both the escalation phase costs and ongoing maintenance expenses. For Wegovy, the first four months total £414.96, covering doses from 0.25mg through 1.7mg using new customer pricing with code FIRST40. From month five onwards, the annual maintenance cost at 2.4mg equals £2,519.88, creating a predictable monthly budget of £209.99. This transparency allows for informed financial planning and helps determine the long-term sustainability of your chosen treatment.
When evaluating Mounjaro vs Wegovy UK annual costs, consider that both treatments typically require long-term commitment for sustained results. Clinical data suggests that discontinuing treatment often leads to weight regain, making the annual cost a crucial factor in treatment selection. Our returning customer discount code DOSE25 helps reduce ongoing costs, and bundle options can streamline your ordering process while securing multiple months of supply. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your clinical needs and budget considerations.
Start Your Treatment: Transparent Pricing and Expert Support
Ready to begin your weight management journey with clear understanding of monthly costs? EverydayMeds provides both Wegovy and Mounjaro with complete price transparency—no hidden fees, no surprise charges, just straightforward monthly investment in your health. New customers use code FIRST40 at checkout, while returning customers apply DOSE25 for ongoing savings. Our clinical team provides ongoing support throughout your treatment, ensuring optimal results from your monthly investment. Visit https://everydaymeds.co.uk/collections/wegovy to start your assessment today. Your weight management success deserves the expertise of a GPhC-registered pharmacy (#9012878) committed to authentic medication and professional care.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
